DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms
FEBS Open Bio · 2024
DOI: 10.1002/2211-5463.13798 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2024. Verfasst von Theadora Vessella und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Worcester Polytechnic Institute, MA, USA. Hauptthemen laut MEDLINE: Neuroblastoma, Discoidin Domain Receptor 2, Transcriptome, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
The extracellular matrix (ECM) regulates carcinogenesis by interacting with cancer cells via cell surface receptors. Discoidin Domain Receptor 2 (DDR2) is a collagen‐activated receptor implicated in cell survival, growth, and differentiation. Dysregulated DDR2 expression has been identified in various cancer types, making it as a promising therapeutic target. Additionally, cancer cells exhibit mechanosensing abilities, detecting changes in ECM stiffness, which is particularly important for carcinogenesis given the observed ECM stiffening in numerous cancer types. Despite these, whether collagen‐activated DDR2 signaling and ECM stiffness‐induced mechanosensing exert similar effects on cancer cell behavior and whether they operate through analogous mechanisms remain elusive. To address these questions, we performed bulk RNA sequencing (RNA‐seq) on human SH‐SY5Y neuroblastoma cells cultured on collagen‐coated substrates. Our results show that DDR2 downregulation induces significant changes in the cell transcriptome, with changes in expression of 15% of the genome, specifically affecting the genes associated with cell division and differentiation. We validated the RNA‐seq results by showing that DDR2 knockdown redirects the cell fate from proliferation to senescence. Like DDR2 knockdown, increasing substrate stiffness diminishes cell proliferation. Surprisingly, RNA‐seq indicates that substrate stiffness has no detectable effect on the transcriptome. Furthermore, DDR2 knockdown influences cellular responses to substrate stiffness changes, highlighting a crosstalk between these two ECM‐induced signaling pathways. Based on our results, we propose that the ECM could activate DDR2 signaling and mechanosensing in cancer cells to orchestrate their cell fate through distinct mechanisms, with or without involving gene expression, thus providing novel mechanistic insights into cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Worcester Polytechnic Institute, MA, USA.
- Bancroft School, Worcester, MA, USA.
- Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Biomedical Engineering, Wichita State University, KS, USA.
- Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA, USA.
ORCID-Profile: Theadora Vessella, Qi Wen
Förderung
- National Science Foundation
Zitieren
APA
Vessella, T., Xiang, S., Xiao, C., Stilwell, M., Fok, J., Shohet, J., Rozen, E., Zhou, H. S., & Wen, Q. (2024). DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13798
Vancouver
Vessella T, Xiang S, Xiao C, Stilwell M, Fok J, Shohet J, et al. DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms. FEBS Open Bio. 2024. doi:10.1002/2211-5463.13798
BibTeX
@article{Vessella2024,
author = {Vessella, Theadora and Xiang, Steven and Xiao, Cong and Stilwell, Madelyn and Fok, Jaidyn and Shohet, Jason and Rozen, Esteban and Zhou, H Susan and Wen, Qi},
title = {DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms},
journal = {FEBS Open Bio},
year = {2024},
doi = {10.1002/2211-5463.13798}
}
EUVIMED